Forecast of Global Clinical Trial Management System 麻豆原创 Growth (Status and Outlook) 2024

Publication ID:

PB24190357

Publication Date:

April 9, 2019

Pages:

138

Publisher:

MRRPB2

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Global Clinical Trial Management System market will register a 9.8% CAGR in terms of revenue, the market size will reach USD 1120 Million by 2024, from USD 700 Million in 2019.

A Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research.
The classification of Clinical Trial Management System includes Enterprise CTMS and Site CTMS. And the proportion of Enterprise CTMS Type in 2017 is about 85%.
Clinical Trial Management System is widely used in Pharma & Biopharmaceutical, Medical Device industry. The most proportion of Clinical Trial Management System is used in Pharma & Biopharmaceutica, and the proportion is about 40%.

According to this study, over the next five years the Clinical Trial Management System market will register a 9.8% CAGR in terms of revenue, the global market size will reach US$ 1120 million by 2024, from US$ 700 million in 2019. In particular, this report presents the global revenue market share of key companies in Clinical Trial Management System business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Clinical Trial Management System market by product type, application, key companies and key regions.

This study considers the Clinical Trial Management System value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Enterprise CTMS
Site CTMS
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Pharma & Biopharmaceutical
Medical Device
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Oracle
Medidata Solutions
PAREXEL
Bioclinica
IBM
Veeva Systems
ERT
DSG
Forte Research Systems
MedNet Solutions
Bio-Optronics
DATATRAK
MasterControl
DZS Software Solutions
ArisGlobal

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Clinical Trial Management System market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Clinical Trial Management System market by identifying its various subsegments.
Focuses on the key global Clinical Trial Management System players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clinical Trial Management System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Clinical Trial Management System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hrs) post payment.

Table Of Contents:

Table of Contents

2019-2024 Global Clinical Trial Management System 麻豆原创 Report (Status and Outlook)

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 麻豆原创 Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Clinical Trial Management System 麻豆原创 Size 2014-2024
2.1.2 Clinical Trial Management System 麻豆原创 Size CAGR by Region
2.2 Clinical Trial Management System Segment by Type
2.2.1 Enterprise CTMS
2.2.2 Site CTMS
2.3 Clinical Trial Management System 麻豆原创 Size by Type
2.3.1 Global Clinical Trial Management System 麻豆原创 Size 麻豆原创 Share by Type (2014-2019)
2.3.2 Global Clinical Trial Management System 麻豆原创 Size Growth Rate by Type (2014-2019)
2.4 Clinical Trial Management System Segment by Application
2.4.1 Pharma & Biopharmaceutical
2.4.2 Medical Device
2.4.3 Other
2.5 Clinical Trial Management System 麻豆原创 Size by Application
2.5.1 Global Clinical Trial Management System 麻豆原创 Size 麻豆原创 Share by Application (2014-2019)
2.5.2 Global Clinical Trial Management System 麻豆原创 Size Growth Rate by Application (2014-2019)

3 Global Clinical Trial Management System by Players
3.1 Global Clinical Trial Management System 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Clinical Trial Management System 麻豆原创 Size by Players (2017-2019)
3.1.2 Global Clinical Trial Management System 麻豆原创 Size 麻豆原创 Share by Players (2017-2019)
3.2 Global Clinical Trial Management System Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Clinical Trial Management System by Regions
4.1 Clinical Trial Management System 麻豆原创 Size by Regions
4.2 Americas Clinical Trial Management System 麻豆原创 Size Growth
4.3 APAC Clinical Trial Management System 麻豆原创 Size Growth
4.4 Europe Clinical Trial Management System 麻豆原创 Size Growth
4.5 Middle East & Africa Clinical Trial Management System 麻豆原创 Size Growth

5 Americas
5.1 Americas Clinical Trial Management System 麻豆原创 Size by Countries
5.2 Americas Clinical Trial Management System 麻豆原创 Size by Type
5.3 Americas Clinical Trial Management System 麻豆原创 Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Clinical Trial Management System 麻豆原创 Size by Countries
6.2 APAC Clinical Trial Management System 麻豆原创 Size by Type
6.3 APAC Clinical Trial Management System 麻豆原创 Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Clinical Trial Management System by Countries
7.2 Europe Clinical Trial Management System 麻豆原创 Size by Type
7.3 Europe Clinical Trial Management System 麻豆原创 Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Clinical Trial Management System by Countries
8.2 Middle East & Africa Clinical Trial Management System 麻豆原创 Size by Type
8.3 Middle East & Africa Clinical Trial Management System 麻豆原创 Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 麻豆原创 Challenges and Impact
9.3 麻豆原创 Trends

10 Global Clinical Trial Management System 麻豆原创 Forecast
10.1 Global Clinical Trial Management System 麻豆原创 Size Forecast (2019-2024)
10.2 Global Clinical Trial Management System Forecast by Regions
10.2.1 Global Clinical Trial Management System Forecast by Regions (2019-2024)
10.2.2 Americas 麻豆原创 Forecast
10.2.3 APAC 麻豆原创 Forecast
10.2.4 Europe 麻豆原创 Forecast
10.2.5 Middle East & Africa 麻豆原创 Forecast
10.3 Americas Forecast by Countries
10.3.1 United States 麻豆原创 Forecast
10.3.2 Canada 麻豆原创 Forecast
10.3.3 Mexico 麻豆原创 Forecast
10.3.4 Brazil 麻豆原创 Forecast
10.4 APAC Forecast by Countries
10.4.1 China 麻豆原创 Forecast
10.4.2 Japan 麻豆原创 Forecast
10.4.3 Korea 麻豆原创 Forecast
10.4.4 Southeast Asia 麻豆原创 Forecast
10.4.5 India 麻豆原创 Forecast
10.4.6 Australia 麻豆原创 Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany 麻豆原创 Forecast
10.5.2 France 麻豆原创 Forecast
10.5.3 UK 麻豆原创 Forecast
10.5.4 Italy 麻豆原创 Forecast
10.5.5 Russia 麻豆原创 Forecast
10.5.6 Spain 麻豆原创 Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt 麻豆原创 Forecast
10.6.2 South Africa 麻豆原创 Forecast
10.6.3 Israel 麻豆原创 Forecast
10.6.4 Turkey 麻豆原创 Forecast
10.6.5 GCC Countries 麻豆原创 Forecast
10.7 Global Clinical Trial Management System Forecast by Type
10.8 Global Clinical Trial Management System Forecast by Application

11 Key Players Analysis
11.1 Oracle
11.1.1 Company Details
11.1.2 Clinical Trial Management System Product Offered
11.1.3 Oracle Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Oracle News
11.2 Medidata Solutions
11.2.1 Company Details
11.2.2 Clinical Trial Management System Product Offered
11.2.3 Medidata Solutions Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Medidata Solutions News
11.3 PAREXEL
11.3.1 Company Details
11.3.2 Clinical Trial Management System Product Offered
11.3.3 PAREXEL Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 PAREXEL News
11.4 Bioclinica
11.4.1 Company Details
11.4.2 Clinical Trial Management System Product Offered
11.4.3 Bioclinica Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Bioclinica News
11.5 IBM
11.5.1 Company Details
11.5.2 Clinical Trial Management System Product Offered
11.5.3 IBM Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 IBM News
11.6 Veeva Systems
11.6.1 Company Details
11.6.2 Clinical Trial Management System Product Offered
11.6.3 Veeva Systems Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Veeva Systems News
11.7 ERT
11.7.1 Company Details
11.7.2 Clinical Trial Management System Product Offered
11.7.3 ERT Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 ERT News
11.8 DSG
11.8.1 Company Details
11.8.2 Clinical Trial Management System Product Offered
11.8.3 DSG Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 DSG News
11.9 Forte Research Systems
11.9.1 Company Details
11.9.2 Clinical Trial Management System Product Offered
11.9.3 Forte Research Systems Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Forte Research Systems News
11.10 MedNet Solutions
11.10.1 Company Details
11.10.2 Clinical Trial Management System Product Offered
11.10.3 MedNet Solutions Clinical Trial Management System Revenue, Gross Margin and 麻豆原创 Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 MedNet Solutions News
11.11 Bio-Optronics
11.12 DATATRAK
11.13 MasterControl
11.14 DZS Software Solutions
11.15 ArisGlobal

12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.